• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

诱导自噬作为非酒精性脂肪性肝病的治疗突破:当前证据与展望

Induction of Autophagy as a Therapeutic Breakthrough for NAFLD: Current Evidence and Perspectives.

作者信息

Liu Yanke, Zhang Mingkang, Wang Yazhi

机构信息

Department of Laboratory Medicine, The First Hospital of Lanzhou University, Lanzhou University, Lanzhou 730000, China.

School of Pharmacy, Lanzhou University, Lanzhou 730000, China.

出版信息

Biology (Basel). 2025 Aug 4;14(8):989. doi: 10.3390/biology14080989.

DOI:10.3390/biology14080989
PMID:40906106
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12383869/
Abstract

Nonalcoholic fatty liver disease (NAFLD) is a clinicopathological syndrome characterised by hepatic steatosis in the absence of significant alcohol consumption or other specific causes of liver injury. It has become one of the leading causes of liver dysfunction worldwide. However, the precise pathophysiological mechanisms underlying NAFLD remain unclear, and effective therapeutic strategies are still under investigation. Autophagy, a vital intracellular process in eukaryotic cells, enables the degradation and recycling of cytoplasmic components through a membrane trafficking pathway. Recent studies have demonstrated a strong association between impaired or deficient autophagy and the development and progression of NAFLD. Restoring autophagic function may represent a key approach to mitigating hepatocellular injury. Nevertheless, due to the complexity of autophagy regulation and its context-dependent effects on cellular function, therapeutic strategies targeting autophagy in NAFLD remain limited. This review aims to summarise the relationship between autophagy and NAFLD, focusing on autophagy as a central mechanism. We discuss the latest research advances regarding interventions such as diet and exercise, pharmacological therapies (including modern pharmacological therapy and plant-derived compounds), and other approaches (such as hormones, nanoparticles, gut microbiota, and vitamins). Furthermore, we briefly highlight potential autophagy-related molecular targets that may offer novel therapeutic insights for NAFLD management.

摘要

非酒精性脂肪性肝病(NAFLD)是一种临床病理综合征,其特征为在无大量饮酒或其他特定肝损伤原因的情况下出现肝脏脂肪变性。它已成为全球肝功能障碍的主要原因之一。然而,NAFLD确切的病理生理机制仍不清楚,有效的治疗策略仍在研究中。自噬是真核细胞中一个重要的细胞内过程,它通过膜运输途径实现细胞质成分的降解和再循环。最近的研究表明,自噬功能受损或缺陷与NAFLD的发生和发展密切相关。恢复自噬功能可能是减轻肝细胞损伤的关键途径。然而,由于自噬调节的复杂性及其对细胞功能的背景依赖性影响,针对NAFLD中自噬的治疗策略仍然有限。本综述旨在总结自噬与NAFLD之间的关系,重点关注自噬这一核心机制。我们讨论了饮食和运动、药物治疗(包括现代药物治疗和植物源化合物)以及其他方法(如激素、纳米颗粒、肠道微生物群和维生素)等干预措施的最新研究进展。此外,我们简要强调了潜在的自噬相关分子靶点,这些靶点可能为NAFLD的管理提供新的治疗思路。

相似文献

1
Induction of Autophagy as a Therapeutic Breakthrough for NAFLD: Current Evidence and Perspectives.诱导自噬作为非酒精性脂肪性肝病的治疗突破:当前证据与展望
Biology (Basel). 2025 Aug 4;14(8):989. doi: 10.3390/biology14080989.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Nonalcoholic Fatty Liver非酒精性脂肪肝
4
Nutritional supplementation for nonalcohol-related fatty liver disease: a network meta-analysis.非酒精性脂肪性肝病的营养补充:一项网状Meta分析。
Cochrane Database Syst Rev. 2021 Jul 19;7(7):CD013157. doi: 10.1002/14651858.CD013157.pub2.
5
Management of urinary stones by experts in stone disease (ESD 2025).结石病专家对尿路结石的管理(2025年结石病专家共识)
Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085.
6
Short-Term Memory Impairment短期记忆障碍
7
Herbal mixture of Platycodon grandiflorum, Cinnamomum cassia, and Asiasarum sieboldii extracts protects against NASH progression via regulation of hepatic steatosis, inflammation, and apoptosis.桔梗、肉桂和细辛提取物的草药混合物通过调节肝脏脂肪变性、炎症和细胞凋亡来预防非酒精性脂肪性肝炎的进展。
Phytomedicine. 2025 Jul 14;145:157077. doi: 10.1016/j.phymed.2025.157077.
8
Effects of a gluten-reduced or gluten-free diet for the primary prevention of cardiovascular disease.减少或无麸质饮食对心血管疾病一级预防的影响。
Cochrane Database Syst Rev. 2022 Feb 24;2(2):CD013556. doi: 10.1002/14651858.CD013556.pub2.
9
Phytotherapy as Multi-Hit Therapy to Confront the Multiple Pathophysiology in Non-Alcoholic Fatty Liver Disease: A Systematic Review of Experimental Interventions.植物疗法作为一种多靶点治疗方法应对非酒精性脂肪性肝病的多种病理生理学:实验干预的系统评价。
Medicina (Kaunas). 2021 Aug 14;57(8):822. doi: 10.3390/medicina57080822.
10
Recent advances in the detection and management of motor dysfunction in Alzheimer's disease.阿尔茨海默病运动功能障碍检测与管理的最新进展
Psychiatriki. 2025 May 14. doi: 10.22365/jpsych.2025.012.

本文引用的文献

1
The effect of an exercise- and passive-induced heat stress on autophagy in young and older males.运动和被动诱导的热应激对年轻男性和老年男性自噬的影响。
Am J Physiol Regul Integr Comp Physiol. 2025 Mar 1;328(3):R289-R299. doi: 10.1152/ajpregu.00232.2024. Epub 2025 Feb 4.
2
Comparison of Glucagon-Like Peptide-1 Receptor Agonists and Sodium-Glucose Cotransporter Protein-2 Inhibitors on Treating Metabolic Dysfunction-Associated Steatotic Liver Disease or Metabolic Dysfunction-Associated Steatohepatitis: Systematic Review and Network Meta-Analysis of Randomised Controlled Trials.胰高血糖素样肽-1受体激动剂与钠-葡萄糖协同转运蛋白2抑制剂治疗代谢功能障碍相关脂肪性肝病或代谢功能障碍相关脂肪性肝炎的比较:随机对照试验的系统评价和网状Meta分析
Endocr Pract. 2025 Apr;31(4):521-535. doi: 10.1016/j.eprac.2024.11.017. Epub 2024 Dec 17.
3
Glucagon-like peptide-1 receptor agonist therapy effects on glycemic control and weight in a primary care clinic population.胰高血糖素样肽-1 受体激动剂治疗对初级保健诊所人群血糖控制和体重的影响。
J Investig Med. 2024 Dec;72(8):911-919. doi: 10.1177/10815589241270427. Epub 2024 Aug 12.
4
Prolonged impacts of sodium glucose cotransporter-2 inhibitors on metabolic dysfunction-associated steatotic liver disease in type 2 diabetes: a retrospective analysis through magnetic resonance imaging.钠-葡萄糖协同转运蛋白2抑制剂对2型糖尿病中代谢功能障碍相关脂肪性肝病的长期影响:一项通过磁共振成像的回顾性分析
Endocr J. 2024 Aug 8;71(8):767-775. doi: 10.1507/endocrj.EJ24-0005. Epub 2024 May 30.
5
GLP1 Receptor Agonists-Effects beyond Obesity and Diabetes.GLP1 受体激动剂——超越肥胖和糖尿病的作用。
Cells. 2023 Dec 28;13(1):65. doi: 10.3390/cells13010065.
6
The intensity-dependent effects of exercise and superimposing environmental heat stress on autophagy in peripheral blood mononuclear cells from older men.运动强度依赖性效应以及叠加环境热应激对老年男性外周血单个核细胞自噬的影响。
Am J Physiol Regul Integr Comp Physiol. 2024 Jan 1;326(1):R29-R42. doi: 10.1152/ajpregu.00163.2023. Epub 2023 Nov 13.
7
Fenofibrate improves hepatic steatosis, insulin resistance, and shapes the gut microbiome via TFEB-autophagy in NAFLD mice.非诺贝特通过 TFEB-自噬改善非酒精性脂肪性肝病小鼠的肝脂肪变性、胰岛素抵抗和肠道微生物组。
Eur J Pharmacol. 2023 Dec 5;960:176159. doi: 10.1016/j.ejphar.2023.176159. Epub 2023 Oct 28.
8
Corn peptides attenuate non-alcoholic fatty liver disease via PINK1/Parkin-mediated mitochondrial autophagy.玉米肽通过PINK1/Parkin介导的线粒体自噬减轻非酒精性脂肪性肝病。
Food Nutr Res. 2023 Sep 29;67. doi: 10.29219/fnr.v67.9547. eCollection 2023.
9
Gemigliptin, a DPP4 inhibitor, ameliorates nonalcoholic steatohepatitis through AMP-activated protein kinase-independent and ULK1-mediated autophagy.西格列汀,一种 DPP4 抑制剂,通过 AMPK 非依赖性和 ULK1 介导的自噬改善非酒精性脂肪性肝炎。
Mol Metab. 2023 Dec;78:101806. doi: 10.1016/j.molmet.2023.101806. Epub 2023 Sep 20.
10
Intermittent fasting activates macrophage migration inhibitory factor and alleviates high-fat diet-induced nonalcoholic fatty liver disease.间歇性禁食激活巨噬细胞移动抑制因子,缓解高脂肪饮食诱导的非酒精性脂肪肝疾病。
Sci Rep. 2023 Aug 11;13(1):13068. doi: 10.1038/s41598-023-40373-5.